iTeos Therapeutics, Inc. (ITOS)
10.15
+0.02 (0.20%)
Inactive · Last trade price
on Aug 28, 2025
iTeos Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | - | 35 | 12.6 | 267.63 | 344.78 | - | Upgrade
|
| Revenue Growth (YoY) | - | 177.89% | -95.29% | -22.38% | - | - | Upgrade
|
| Gross Profit | - | 35 | 12.6 | 267.63 | 344.78 | - | Upgrade
|
| Selling, General & Admin | 45.08 | 49.08 | 50.4 | 43.95 | 40.51 | 15.34 | Upgrade
|
| Research & Development | 158.26 | 142.73 | 109.77 | 96.19 | 59.37 | 29.61 | Upgrade
|
| Operating Expenses | 203.34 | 191.81 | 160.17 | 140.13 | 99.87 | 44.95 | Upgrade
|
| Operating Income | -203.34 | -156.81 | -147.57 | 127.5 | 244.9 | -44.95 | Upgrade
|
| Interest & Investment Income | 29 | 30.87 | 31.77 | 11.36 | 0.08 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 4.71 | 5.6 | 6.77 | 9.88 | 11.49 | 6.86 | Upgrade
|
| Pretax Income | -190.04 | -120.34 | -109.03 | 148.74 | 256.46 | -38.09 | Upgrade
|
| Income Tax Expense | 12.37 | 14.07 | 3.61 | 52.08 | 41.94 | -0.06 | Upgrade
|
| Net Income | -202.41 | -134.41 | -112.64 | 96.65 | 214.52 | -38.03 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 5.37 | Upgrade
|
| Net Income to Common | -202.41 | -134.41 | -112.64 | 96.65 | 214.52 | -43.4 | Upgrade
|
| Net Income Growth | - | - | - | -54.95% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 43 | 40 | 36 | 36 | 35 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 40 | 36 | 38 | 38 | 15 | Upgrade
|
| Shares Change (YoY) | 17.71% | 13.17% | -5.30% | -0.02% | 150.49% | 7336.28% | Upgrade
|
| EPS (Basic) | -4.68 | -3.32 | -3.15 | 2.72 | 6.10 | -2.88 | Upgrade
|
| EPS (Diluted) | -4.68 | -3.32 | -3.15 | 2.56 | 5.68 | -2.88 | Upgrade
|
| EPS Growth | - | - | - | -54.93% | - | - | Upgrade
|
| Free Cash Flow | -108.69 | -99.81 | -106.72 | -112.13 | 511.96 | -25.53 | Upgrade
|
| Free Cash Flow Per Share | -2.51 | -2.47 | -2.98 | -2.97 | 13.55 | -1.69 | Upgrade
|
| Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | - | -448.03% | -1171.69% | 47.64% | 71.03% | - | Upgrade
|
| Profit Margin | - | -384.04% | -894.34% | 36.11% | 62.22% | - | Upgrade
|
| Free Cash Flow Margin | - | -285.18% | -847.34% | -41.90% | 148.49% | - | Upgrade
|
| EBITDA | -202.05 | -155.57 | -146.68 | 128.3 | 245.5 | -44.42 | Upgrade
|
| EBITDA Margin | - | - | - | 47.94% | 71.21% | - | Upgrade
|
| D&A For EBITDA | 1.29 | 1.24 | 0.9 | 0.8 | 0.6 | 0.54 | Upgrade
|
| EBIT | -203.34 | -156.81 | -147.57 | 127.5 | 244.9 | -44.95 | Upgrade
|
| EBIT Margin | - | - | - | 47.64% | 71.03% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 35.02% | 16.35% | - | Upgrade
|
| Revenue as Reported | - | 35 | 12.6 | 267.63 | 344.78 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.